547
Views
0
CrossRef citations to date
0
Altmetric
Review

Contraceptive methods in adolescence: a narrative review of guidelines

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 51-57 | Received 15 Jun 2022, Accepted 20 Dec 2022, Published online: 13 Jan 2023

References

  • Ott MA, Sucato GS, Committee on Adolescnence. Contraception for adolescents. Pediatrics. 2014;134(4):e1257–e1281.
  • American College of Obstetricians and Gynecologists. Adolescent pregnancy, contraception and sexual activity. Committee opinion no. 699. Obstet Gynecol. 2017;129:e142–e149.
  • Sedgh G, Finer LB, Bankole A, et al. Adolescent pregnancy, birth, and abortion rates across countries: levels and recent trends. J Adolesc Health. 2015;56(2):223–230.
  • American College of Obstetricians and Gynecologists. Counseling adolescents about contraception. Committee opinion no. 710. Obstet Gynecol. 2017;130:e74–80.
  • Finer LB, Zolna MR. Declines in unintended pregnancy in the United States, 2008–2011. N Engl J Med. 2016;374(9):843–852.
  • Abma JC, Martinez GM. Sexual activity and contraceptive use among teenagers in the United States, 2011-2015. Natl Health Stat Report. 2017;2017:1–22.
  • Raidoo S, Kaneshiro B. Contraception counseling for adolescents. Curr Opin Obstet Gynecol. 2017;29(5):310–315.
  • World Health Organization. Adolescent contraceptive use: glossary of terms. WHO; 2016. Available from: https://apps.who.int/iris/handle/10665/252536
  • Hock-Long L, Herceg-Baron R, Cassidy AM, et al. Access to adolescent reproductive health services: financial and structural barriers to care. Perspect Sex Reprod Health. 2003;35(3):144–147.
  • Maravilla JC, Betts KS, Couto e Cruz C, et al. Factors influencing repeated teenage pregnancy: a review and meta-analysis. Am J Obstet Gynecol. 2017;217(5):527–545.e31.
  • Di Meglio G, Crowther C, Simms J. Contraceptive care for Canadian youth. Paediatr Child Health. 2018;23(4):271–277.
  • American College of Obstetricians and Gynecologists. ACOG Committee Opinion No. 735. Adolescents and long-acting reversible contraception: implants and intrauterine devices. Obstet Gynecol. 2018;131(735):e130–e139.
  • Faculty of Sexual & Reproductive Healthcare Clinical Effectiveness Unit. Contraceptive choices for young people. J Pediatr Adolesc Gynecol. 2020;32:100048.
  • Black A, Guilbert E, Costescu D, et al. Canadian contraception consensus (part 1 of 4). J Obstet Gynaecol Canada. 2015;37(10):936–938.
  • Black A, Guilbert E, Costescu D, et al. Canadian contraception consensus (part 2 of 4). J Obstet Gynaecol Canada. 2015;37(11):1033–1035.
  • Black A, Guilbert E, Costescu D, et al. Canadian contraception consensus (part 3 of 4): chapter 7 - intrauterine contraception. J Obstet Gynaecol Can. 2016;38(2):182–222.
  • MacGregor KE, Khadr SN. Contraception for adolescents (American Academy of Pediatrics). Arch Dis Child Educ Pract Ed. 2016;101(2):61–64.
  • Curtis KM, Jatlaoui TC, Tepper NK, et al. U.S. selected practice recommendations for contraceptive use. MMWR Recomm Rep. 2016;65(4):1–66.
  • National Institute for Health and Care Excellence. Contraceptive services with a focus on young people aged up to 25. Public Health Guideline (PH51) 2014;25:1–29. Available from: www.nice.org.uk/guidance/ph51
  • World Health Organization, Department of Reproductive Health and Research, Guidelines Review Committee. Medical eligibility criteria for contraceptive use: a WHO family planning cornerstone. Geneva: WHO; 2015. p. 210.
  • Menon S, Alderman EM, Chung RJ, et al. Long-acting reversible contraception: specific issues for adolescents. Pediatrics. 2020;146(2):e2020007252.
  • Creinin M, Kohn JE, Tang JH, et al. Society of Family Planning Committee statement on IUD nomenclature. Contraception. 2022;106:1–2.
  • Hartman LB, Monasterio E, Hwang LY. Adolescent contraception: review and guidance for pediatric clinicians. Curr Probl Pediatr Adolesc Health Care. 2012;42(9):221–263.
  • Croxatto HB. Mechanisms that explain the contraceptive action of progestin implants for women. Contraception. 2002;65(1):21–27.
  • Thaxton L, Lavelanet A. Systematic review of efficacy with extending contraceptive implant duration. Int J Gynaecol Obstet. 2019;144(1):2–8.
  • Ali M, Akin A, Bahamondes L, et al. Extended use up to 5 years of the etonogestrel-releasing subdermal contraceptive implant: comparison to levonorgestrel-releasing subdermal implant. Hum Reprod. 2016;31(11):2491–2498. https://academic.oup.com/humrep/article/31/11/2491/2274325.
  • McNicholas C, Swor E, Wan L, et al. Prolonged use of the etonogestrel implant and levonorgestrel intrauterine device: 2 years beyond Food and Drug Administration-approved duration. Am J Obstet Gynecol. 2017;216(6):586.e1–586.e6.
  • Winner B, Peipert JF, Zhao Q, et al. Effectiveness of long-acting reversible contraception. Obstet Gynecol Surv. 2012;67(9):552–553.
  • Wilson SF, Strohsnitter W, Baecher-Lind L. Practices and perceptions among pediatricians regarding adolescent contraception with emphasis on intrauterine contraception. J Pediatr Adolesc Gynecol. 2013;26(5):281–284.
  • Schindler AE, Campagnoli C, Druckmann R, et al. Reprint of classification and pharmacology of progestins. Maturitas. 2008;61(1–2):171–180. http://www.maturitas.org/article/S0378512208003514/fulltext.
  • Apter D. International perspectives: IUDs and adolescents. J Pediatr Adolesc Gynecol. 2019;32(5S):S36–S42.
  • Golden NH. Bones and birth control in adolescent girls. J Pediatr Adolesc Gynecol. 2020;33(3):249–254.
  • Beerthuizen R, van Beek A, Massai R, et al. Bone mineral density during long-term use of the progestagen contraceptive implant implanon® compared to a non-hormonal method of contraception. Hum Reprod. 2000;15(1):118–122.
  • Apter D. Contraception options: aspects unique to adolescent and young adult. Best Pract Res Clin Obstet Gynaecol. 2018;48:115–127.
  • Adeyemi-Fowode OA, Bercaw-Pratt JL. Intrauterine devices: effective contraception with noncontraceptive benefits for adolescents. J Pediatr Adolesc Gynecol. 2019;32(5S):S2–S6.
  • Society for Adolescent Health and Medicine. Improving knowledge about, access to, and utilization of long-acting reversible contraception among adolescents and young adults. J Adolesc Heal. 2017;60:472–474.
  • Black A, Guilbert E, Costescu D, et al. Canadian contraception consensus part 4 of 4 chapter 9: combined hormonal contraception. J Obstet Gynaecol Can. 2017;39(4):229–268.e5.
  • Duranteau L. Contraception for adolescents. Med Ther Pediatr. 2018;21:101–111.
  • Festin MPR. Overview of modern contraception. Best Pract Res Clin Obstet Gynaecol. 2020;66:4–14.
  • Cromer BA, Blair JMA, Mahan JD, et al. A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (norplant), or oral contraceptives. J Pediatr. 1996;129(5):671–676.
  • American College of Obstetricians and Gynecologists. Depot medroxyprogesterone acetate and bone effects. Committee Opinion No. 602. Obstet Gynecol. 2014;123:1396–1402.
  • Kiley J, Hammond C. Combined oral contraceptives: a comprehensive review. Clin Obstet Gynecol. 2007;50(4):868–877.
  • Jin J. Oral contraceptives. J Am Med Assoc. 2014;311(3):321.
  • Howard B, Trussell J, Grubb E, et al. Comparison of pregnancy rates in users of extended and cyclic combined oral contraceptive (COC) regimens in the United States: a brief report. Contraception. 2014;89(1):25–27.
  • Halpern V, Lopez LM, Grimes DA, et al. Strategies to improve adherence and acceptability of hormonal methods of contraception. Cochrane Database Syst Rev. 2013;(10):CD004317.
  • Zapata LB, Steenland MW, Brahmi D, et al. Patient understanding of oral contraceptive pill instructions related to missed pills: a systematic review. Contraception. 2013;87(5):674–684.
  • Chabbert-Buffet N, Jamin C, Lete I, et al. Missed pills: frequency, reasons, consequences and solutions. Eur J Contracept Reprod Health Care. 2017;22(3):165–169.
  • Bagshaw S. The combined oral contraceptive: risks and adverse effects in perspective. Drug Saf. 1995;12(2):91–96. http://www.embase.com/search/results?subaction=viewrecord&from=export&id=L25070370%5Cnhttp://sfx.library.uu.nl/utrecht?sid=EMBASE&issn=01145916&id=doi:&atitle=The+combined+oral+contraceptive%3A+Risks+and+adverse+effects+in+perspective&stitle=DRUG+SAF.&tit.
  • Trenor CC, Chung RJ, Michelson AD, et al. Hormonal contraception and thrombotic risk: a multidisciplinary approach. Pediatrics. 2011;127(2):347–357.
  • Jick SS, Hagberg KW, Kaye JA, et al. The risk of unintended pregnancies in users of the contraceptive patch compared to users of oral contraceptives in the UK General Practice Research Database. Contraception. 2009;80(2):142–151.
  • Wagner MS, Black A. The combined contraceptive vaginal ring: an update. Curr Obstet Gynecol Rep. 2016;5(1):1–12.
  • Galzote R, Rafie S, Teal R, et al. Transdermal delivery of combined hormonal contraception: a review of the current literature. Int J Womens Health. 2017;9:315–321.
  • O’Brien RF, Warner L, Blythe MJ, et al. Condom use by adolescents. Pediatrics. 2013;132(5):973–981.
  • Ellen JM, Adler N, Gurvey JE, et al. Adolescent condom use and perceptions of risk for sexually transmitted diseases: a prospective study. Sex Transm Dis. 2002;29(12):756–762.
  • Manlove J, Ikramullah E, Terry-Humen E. Condom use and consistency among male adolescents in the United States. J Adolesc Health. 2008;43(4):325–333.
  • Brown LK, DiClemente R, Crosby R, et al. Condom use among high-risk adolescents: anticipation of partner disapproval and less pleasure associated with not using condoms. Public Health Rep. 2008;123(5):601–607.
  • Bearinger LH, Resnick MD. Dual method use in adolescents: a review and framework for research on use of STD and pregnancy protection. J Adolesc Heal. 2003;32(5):340–349.
  • Westhoff C, Kerns J, Morroni C, et al. Quick start: a novel oral contraceptive initiation method. Contraception. 2002;66(3):141–145.
  • World Health Organization Department of Reproductive Health and Research (WHO/RHR) and Johns Hopkins Bloomberg School of Public Health/Center for Communication Programs (CCP). Knowledge for health project. Family planning: a global handbook for providers (2018 update). Baltimore and Geneva: CCP and WHO; 2018.
  • Westhoff C, Heartwell S, Edwards S, et al. Initiation of oral contraceptives using a quick start compared with a conventional start: a randomized controlled trial. Obstet Gynecol. 2007;109(6):1270–1276.
  • Lara-Torre E, Schroeder B. Adolescent compliance and side effects with quick start initiation of oral contraceptive pills. Contraception. 2002;66(2):81–85.
  • Center for Reproductive Health Education In Family Medicine, Department of Family and Social Medicine - Montefiore Medical Center. Quick start algorithm. https://www.rhedi.org/quick-start-algorithms/.
  • Upadhya KK, Breuner CC, Alderman EM, et al. Emergency contraception. Pediatrics. 2019;144(6):e20193149.
  • Cleland K, Raymond EG, Westley E, et al. Emergency contraception review: evidence-based recommendations for clinicians. Clin Obstet Gynecol. 2014;57(4):741–750.
  • Mansour D, Inki P, Gemzell-Danielsson K. Efficacy of contraceptive methods: a review of the literature. Eur J Contracept Reprod Health Care. 2010;15(1):4–16.
  • Coles MS, Urbach K, Conard LAE, et al. Emergency contraception for adolescents and young adults: guidance for health care professionals the society for adolescent health and medicine. J Adolesc Heal. 2016;58:245–248. Available from:
  • Edelman AB, Cherala G, Blue SW, et al. Impact of obesity on the pharmacokinetics of levonorgestrel based emergency contraception: single and double dosing. Contraception. 2016;94(1):52–57.
  • Raymond EWE, Blithe D, et al. Safety and effectiveness data for emergency contraceptive pills among women with obesity: a systematic review. Int Consort Emerg Contracept Int Fed Gynecol Obstet. 2012;63:16.
  • Dehlendorf C, Krajewski C, Borrero S. Contraceptive counseling: best practices to ensure quality communication and enable effective contraceptive use. Clin Obstet Gynecol. 2014;57(4):659–673.
  • Bitzer J, Abalos V, Apter D, et al. Targeting factors for change: contraceptive counselling and care of female adolescents. Eur J Contracept Reprod Health Care. 2016;21(6):417–430.
  • Merki-Feld GS, Bitzer J. Contraception in adolescents with anorexia nervosa. Is there evidence for a negative impact of combined hormonal contraceptives on bone mineral density and the course of the disease? Eur J Contracept Reprod Health Care. 2020;25(3):213–220.
  • Nunes FRP, Das Neves FA, Geraldes F, et al. Contraception in adolescents with intellectual disability. Eur J Contracept Reprod Health Care. 2017;22(6):401–406.
  • Savioja H, Helminen M, Fröjd S, et al. Delinquency and sexual experiences across adolescence: does depression play a role? Eur J Contracept Reprod Health Care. 2017;22(4):298–304.
  • Sober S, Shea J, Shaber A, et al. Postpartum adolescents’ contraceptive counselling preferences. Eur J Contracept Reprod Health Care. 2017;22(2):83–87.
  • Barrense-Dias Y, Stadelmann S, Suris JC, et al. From request to dispensation: how adolescent and young adult females experience access to emergency contraception in pharmacies. Eur J Contracept Reprod Health Care. 2022;22:1–6.
  • Ragnar ME, Grandahl M, Stern J, et al. Important but far away: adolescents’ beliefs, awareness and experiences of fertility and preconception health. Eur J Contracept Reprod Health Care. 2018;23(4):265–273.
  • Sekine K, Khadka N, Carandang RR, et al. Mulitlevel factors influencing contraceptive use and childbearing among adolescent girls in Bara district of Nepal: a qualitative study using the socioecological model. BMJ Open. 2021;11(10):e046156.
  • Claringbold L, Sanci L, Temple-Smith M. Factors influencing young women’s contraceptive choices. Aust J Gen Pract. 2019;48(6):389–394.
  • Nunes Reis Y, Vilela AL, de Souza Costa A, et al. Factors associated with adolescents’ choice to use long acting reversible contraceptives: a systematic review. Curr Obstet Gynecol Rep. 2018;7(4):153–162.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.